Department of Critical Care, 1333St Peter's Hospital, Surrey, United Kingdom.
J Intensive Care Med. 2021 Feb;36(2):229-232. doi: 10.1177/0885066620955137. Epub 2020 Sep 30.
A minority of patients with Severe Acutre Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) disease-2019 (Covid-19) develop pulmonary features consistent with the Acute Respiratory Distress Syndrome (ARDS). Prone positioning (PP) is an intervention with proven survival benefits in moderate-to-severe and severe ARDS. It is advocated in international guidelines as an intervention in mechanically ventilated Covid-19 patients, despite very few published trials investigating its efficacy in Covid-19. There is an ongoing debate regarding the prevalence of reported mismatches between the severity of hypoxaemia and the preservation of pulmonary compliance in some patients, in the early stages of SARS-CoV-2 infection. This has led some to question its utility within this context. 129 proning sessions were identified in 34 consecutively prone patients admitted to the intensive care unit at a single center in the United Kingdom. Baseline characteristics of patients were consistent with previously published national and international reports and patients were ventilated in general concordance with the ARDSnet ventilation protocol. Paired analysis of the partial pressure of arterial oxygen(PaO): fraction of inspired oxygen(FiO) ratio (PF ratio) (n = 89) and FiO (n = 129) was recorded within 3 hours of both the initiation and termination of PP and differences were assessed with the paired Student's -test and Wilcoxon Signed-Rank test. Proning improved the PF ratio by 43.5 ± 54.9 from 99.8 ± 37.5 to 151.9 ± 58.9 (43.6% increase) [ 0.0001] and reduced FiO by 0.17 ± 0.2 from 0.68 ± 0.2 to 0.51 ± 0.2 (25% decrease) [ < 0.0001]. 82% of proning maneouveres resulted in an improvement in the PF ratio. In summary, PP improved arterial oxygenation and reduced oxygen requirements in most Covid-19 patients in this single- center, retrospective analysis.
少数患有严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)疾病 2019 年(Covid-19)的患者会出现符合急性呼吸窘迫综合征(ARDS)的肺部特征。俯卧位通气(PP)是一种已被证明可提高中重度和重度 ARDS 患者生存率的干预措施。尽管关于俯卧位通气在 Covid-19 患者中的疗效的试验很少,但国际指南仍提倡将其作为机械通气 Covid-19 患者的干预措施。在 SARS-CoV-2 感染的早期阶段,一些患者存在低氧血症严重程度与肺顺应性保存之间的报告不匹配的情况,这引发了人们对其在这种情况下的实用性的质疑。在英国的一家单一中心的重症监护病房中,连续俯卧位的 34 名患者中确定了 129 次俯卧位治疗。患者的基线特征与之前发表的全国性和国际性报告一致,患者的通气与 ARDSnet 通气方案基本一致。记录了 89 例患者动脉血氧分压(PaO)与吸入氧分数(FiO)比值(PF 比值)和 129 例患者 FiO 比值(n = 89)在俯卧位开始和结束后 3 小时内的配对分析,并通过配对学生 t 检验和 Wilcoxon 符号秩检验评估差异。俯卧位通气将 PF 比值从 99.8 ± 37.5 提高到 151.9 ± 58.9(提高 43.6%)[0.0001],将 FiO 降低 0.17 ± 0.2,从 0.68 ± 0.2 降至 0.51 ± 0.2(降低 25%)[<0.0001]。82%的俯卧位通气操作改善了 PF 比值。总之,在这项单中心回顾性分析中,PP 改善了大多数 Covid-19 患者的动脉氧合,并降低了氧气需求。